Considerations for using distributed research networks to conduct aspects of randomized trials

Stakeholders in the clinical research enterprise are aligned around the need to make clinical research in general, and randomized controlled trials in particular, more meaningful and efficient. To that end, we have built distributed research networks (DRNs) for the Sentinel System, the National Inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsolo, Keith A., Brown, Jeffrey S., Hernandez, Adrian F., Hammill, Bradley G., Raman, Sudha R., Syat, Beth, Platt, Richard, Curtis, Lesley H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961060/
https://www.ncbi.nlm.nih.gov/pubmed/31956724
http://dx.doi.org/10.1016/j.conctc.2019.100515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961060/
https://www.ncbi.nlm.nih.gov/pubmed/31956724
http://dx.doi.org/10.1016/j.conctc.2019.100515

Ejemplares similares